Biocon and Serum Institute come together with strategic alliance to increase vaccine access for developing countries
As part of the deal, the BBL has offered 15% stake to SILS at a post money valuation of $4.9 billion in exchange for committed access to 100 million doses of vaccines per annul for 15 years.
Research and manufacturing infrastructure will also be leveraged by this partnership for opportunities in infectious diseases,” Shaw said.
The company along with its subsidiaries has entered into a confidential settlement agreement with Celgene Corporation, a wholly-owned subsidiary of Bristol Myers Squibb.
Initial data indicate that ADG20 could provide both rapid and durable protection against COVID-19 for up to one year, Biocon Biologics said.
Insider trading case: Sebi bars Biocon's official from securities market for three months, levies fine
Biocon had announced information relating to its collaboration with Sandoz and the period of unpublished price sensitive information (UPSI) was from December 20, 2017 to January 18, 2018.
Mazumdar-Shaw is one of the key speakers at the 15th edition of the annual virtual summit on June 22 hosted by the USA India Chambers of Commerce.
Mazumdar-Shaw, the executive chairperson of biotechnology major Biocon, in a lighter vein compared the two while bringing out the confusion that currently prevails regarding the vaccination process.
A Belagavi-based pharmaceutical company has been roped in to manufacture ‘Remidesvir’, which is given to critical Covid patients and is in short supply across the country.
The certificate, which includes manufacturing and packaging of tablets and capsules in the non-potent and potent blocks of the facility, was issued based on a remote inspection in March 22.